Process for preparing maytansinoid antibody conjugates

Details for Australian Patent Application No. 2006213662 (hide)

Owner ImmunoGen, Inc.

Inventors Chari, Ravi; Dai, Yong; Meshulam, Deborah H.; Amphlett, Godfrey W.; Zhang, Wei; Wang, Yong

Agent Fisher Adams Kelly

Pub. Number AU-B-2006213662

PCT Pub. Number WO2006/086733

Priority 60/652,434 11.02.05 US

Filing date 10 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 5 August 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086733 Priority application(s): WO2006/086733

5 August 2010 Application Accepted

  Published as AU-B-2006213662

19 August 2010 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Process for preparing stable drug conjugates. Address for service in Australia - Fisher Adams Kelly Level 29 12 Creek Street Brisbane QLD 4000

9 December 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Process for preparing stable drug conjugates

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213663-Substituted propane phosphinic acid esters

2006213659-Inhibiting HER2 shedding with matrix metalloprotease antagonists